drugset / Trial / NCT01373086
LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will assess the efficacy and safety of LFF269 compared to placebo after treatment in subjects with essential hypertension.
Timeline
- Start
- 2011-05
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Eplerenone | Unknown | 50 mg | — |
| Subject | LFF269 | Unknown | — | — |